# DRUG ELUTING STENT FOR DIABETIC PATIENTS IN CORONARY ARTERY DISEASE TREATMENT

> **NCT03509532** · — · UNKNOWN · sponsor: **I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio** · enrollment: 5000 (estimated)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DEVICE:** PCI

## Key facts

- **NCT ID:** NCT03509532
- **Lead sponsor:** I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-01
- **Primary completion:** 2019-01
- **Final completion:** 2022-01
- **Target enrollment:** 5000 (ESTIMATED)
- **Last updated:** 2018-04-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03509532

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03509532, "DRUG ELUTING STENT FOR DIABETIC PATIENTS IN CORONARY ARTERY DISEASE TREATMENT". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03509532. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*